Impact of Atypical Antipsychotics as Adjunctive Therapy on Psychiatric Cost and Utilization in Patients with Major Depressive Disorder

INTRODUCTION: Patients with major depressive disorder (MDD) incur high costs, despite established treatment options. Adding an atypical antipsychotic (AAP) to antidepressant therapy has shown to reduce depressive symptoms in MDD, but it remains unclear with which adjunctive AAP to initiate. As econo...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clinicoecon Outcomes Res
Päätekijät: Yan, Tingjian, Greene, Mallik, Chang, Eunice, Houle, Christy R, Tarbox, Marian H, Broder, Michael S
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Dove 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7012250/
https://ncbi.nlm.nih.gov/pubmed/32104020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEOR.S231824
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia